This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

Meril has announced the appointment of Biplab G. as its Business Head - APAC, Arthroplasty Portfolio, based in Mumbai, with a ...

Meril Life Sciences' Myval THV shows comparable safety, efficacy, and QoL outcomes in the global LANDMARK trial, positioning ...

Meril Life Sciences today announced one-year results from a pivotal trial evaluating its balloon-expandable Myval THV system.

Glamour, nostalgia, and fresh talent lit up the 26th Meril-Prothom Alo Awards in a heartfelt celebration of Bangladesh’s entertainment industry ...

Looking toward approval in the US, larger studies with careful hemodynamic data will be needed, says Martin Leon.

The 26th edition of the Meril-Prothom Alo Awards was held at the Bangladesh-China Friendship Conference Centre in Agargaon ...

Meril Life Sciences announced one-year results from its pivotal LANDMARK trial, presented during the prestigious ...

The Myval THV series demonstrated non-inferiority to contemporary THVs in terms of 1-year clinical efficacy composite endpoint (Myval THV Series: 13% vs. Contemporary THV: 13.1%, difference: -0.1% ...

Mr. Sanjeev Bhatt,Senior Vice President – Corporate Strategy at Meril, said:“The LANDMARKtrial represents a significant milestone not just for Meril, but for the global TAVI community.

First-of-its-kind head-to-head TAVI trial reinforces the performance and safety of the Next Gen Myval THV series VAPI, India, May 22, 2025 /PRNewswire/ -- Meril Life Sciences announced one-year ...